Taysha Gene Therapies Inc (TSHA) — Cash Flow Reinvestment Rate
Taysha Gene Therapies Inc (TSHA) has a Cash Flow Reinvestment Rate of 0.33x as of December 2022, reinvesting $4.68 Million (capex $2.31 Million plus investments $-2.37 Million) from operating cash flow of $14.28 Million. Explore Taysha Gene Therapies Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Taysha Gene Therapies Inc Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Taysha Gene Therapies Inc across 1 annual periods. Also explore Taysha Gene Therapies Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Taysha Gene Therapies Inc (2019–2019)
Year-by-year capital reinvestment analysis for Taysha Gene Therapies Inc. For live market cap and broader valuation context, see Taysha Gene Therapies Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.61x | $82.00K | $135.00K | $82.00K | — |